Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2,026 DKK | +1.20% | -1.84% | -5.94% |
05-21 | Genmab A/S completed the acquisition of ProfoundBio, Inc. | CI |
05-15 | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.94% | 18.8B | |
+8.63% | 114B | |
+13.17% | 107B | |
-12.76% | 22.22B | |
-2.53% | 21.28B | |
-7.19% | 17.51B | |
-39.93% | 17.17B | |
+6.67% | 14.14B | |
+33.90% | 12.2B | |
-28.60% | 7.83B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Morgan Stanley Trims Price Target on Genmab to $33 From $34, Maintains Underweight Rating